This Employment Agreement (the "Agreement") is dated as of June 19, --------- 1998, by and between James E. Brown ("Employee") and Durect Therapeutics -------- Corporation, a Delaware corporation (the "Company"). -------Employment Agreement • April 20th, 2000 • Durect Corp • California
EXHIBIT 1.1 _______________Shares DURECT CORPORATION Common Stock, Par Value $0.0001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • April 20th, 2000 • Durect Corp • New York
AGREEMENT ---------Rights Agreement • April 20th, 2000 • Durect Corp • Delaware
AGREEMENT ---------Indemnification Agreement • April 20th, 2000 • Durect Corp • Delaware
CONFIDENTIAL EXHIBIT 10.23 [LOGO FOR PACIFIC DATA] MASTER AGREEMENTMaster Agreement • July 28th, 2000 • Durect Corp • Pharmaceutical preparations • California
EXHIBIT 10.17 DURECT CORPORATION COMMON STOCK PURCHASE AGREEMENT -------------------------------Common Stock Purchase Agreement • April 20th, 2000 • Durect Corp • California
FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT] DURECT CORPORATIONDurect Corp • February 7th, 2023 • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised (the “Termination Date”) but not thereafter, to subscribe for and purchase from DURECT Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.12 November 24, 1999 James Griffin V.P. Manufacturing Ciena Corporation/Core Switching Division 10201 Bubb Road Cupertino, CA 95014 Re: Sublease Amendment Dear Jim: This Letter Agreement is entered into between Durect Corporation...Letter Agreement • April 20th, 2000 • Durect Corp
DURECT Corporation 17,708,333 Shares of Common Stock (par value $0.0001 per share) Underwriting AgreementUnderwriting Agreement • February 5th, 2021 • Durect Corp • Pharmaceutical preparations • New York
DURECT Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of up to 17,708,333 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). The 17,708,333 shares of Common Stock to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,656,249 shares of Common Stock, which are collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as u
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 21st, 2023 • Durect Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 19, 2023, between DURECT Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER dated as of April 18, 2001Agreement and Plan of Merger • May 15th, 2001 • Durect Corp • Pharmaceutical preparations • Alabama
DURECT CORPORATION Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementDurect Corp • November 3rd, 2015 • Pharmaceutical preparations • New York
DURECT Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Controlled Equity OfferingSM Sales AgreementSales Agreement • July 30th, 2021 • Durect Corp • Pharmaceutical preparations • New York
DURECT Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
EXHIBIT 10.16 DURECT THERAPEUTICS CORPORATION EMPLOYMENT AGREEMENT --------------------Employment Agreement • April 20th, 2000 • Durect Corp • California
EXHIBIT 10.20 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 1st, 2000 • Durect Corp • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE...Durect Corp • April 20th, 2000 • California
COMMON STOCK PURCHASE WARRANT DURECT CORPORATIONDurect Corp • July 21st, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DURECT Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 1st, 2016 • Durect Corp • Pharmaceutical preparations
THIS LOAN AND SECURITY AGREEMENT (as the same may from time to time be amended, modified, supplemented or restated, this “Agreement”) dated as of July 28, 2016 (the “Effective Date”), among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”), and DURECT CORPORATION, a Delaware corporation with offices located at 10260 Bubb Road, Cupertino, CA 95014 (“Borrower”), provides the terms on which the Lenders shall lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
RECITALSManufacturing and Supply Agreement • April 20th, 2000 • Durect Corp • Colorado
AGREEMENT ---------Preferred Shares Rights Agreement • July 10th, 2001 • Durect Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.8 ================================================================== ============== AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT DURECT CORPORATION TABLE OF CONTENTSNegative Pledge Agreement • April 20th, 2000 • Durect Corp
REGISTRATION RIGHTS AGREEMENT among DURECT CORPORATION as Issuer, and MORGAN STANLEY & CO. INCORPORATED, as Initial Purchaser Dated as of June 18, 2003Registration Rights Agreement • August 8th, 2003 • Durect Corp • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT dated as of June 18, 2003 between DURECT Corporation, a Delaware corporation (the “Company”), and Morgan Stanley & Co. Incorporated, (the “Initial Purchaser”) pursuant to the Purchase Agreement dated June 12, 2003 (the “Purchase Agreement”), between the Company and the Initial Purchaser. In order to induce the Initial Purchaser to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement.
CONFIDENTIAL EXHIBIT 10.24 MASTER SERVICE AGREEMENT INTRODUCTION: This Agreement ("Agreement") is entered into by and between Clinimetrics Research Associates, Inc., a contract research organization, with its principal office and place of business at...Master Service Agreement • July 28th, 2000 • Durect Corp • Pharmaceutical preparations • California
FORM OF COMMON STOCK PURCHASE WARRANT] DURECT CORPORATIONDurect Corp • February 7th, 2023 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_], 202[_]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DURECT Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE AGREEMENT Dated as of July 1, 2010 by and between DURECT CORPORATION and AZIMUTH OPPORTUNITY LTD.Common Stock Purchase Agreement • July 1st, 2010 • Durect Corp • Pharmaceutical preparations • New York
This COMMON STOCK PURCHASE AGREEMENT, made and entered into on this 1st day of July 2010 (this “Agreement”), by and between Azimuth Opportunity Ltd., an international business company incorporated under the laws of the British Virgin Islands (the “Investor”), and DURECT Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in Annex A hereto.
Exhibit 10.31 THIRD AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 14th, 2002 • Durect Corp • Pharmaceutical preparations • California
DURECT CORPORATION 14,000,000 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • December 6th, 2012 • Durect Corp • Pharmaceutical preparations • New York
Durect Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriter named in Schedule I hereto (the “Underwriter”) an aggregate of 14,000,000 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”).
RECITALS --------Market Stand-Off Agreement • April 20th, 2000 • Durect Corp • California
DURECT CORPORATION 12,000,000 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • April 29th, 2016 • Durect Corp • Pharmaceutical preparations • New York
Durect Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”) an aggregate of 12,000,000 shares (the “Firm Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The Firm Shares include 360,000 shares of Common Stock (the “Other Firm Shares”) to be purchased by a person previously agreed upon between the Company and the Underwriters. The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 1,800,000 shares of common stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
RECITALSProduct Acquisition Agreement • September 1st, 2000 • Durect Corp • Pharmaceutical preparations • California
PARTIES This Lease, dated the 14th day of May, 2003 for reference purposes only, is entered into by and between Renault & Handley Employees Investment Co. and Durect Corporation, a Delaware corporation hereinafter referred to respectively as “Lessor”...Durect Corp • March 11th, 2004 • Pharmaceutical preparations
LEASE AGREEMENTLease Agreement • March 15th, 2007 • Durect Corp • Pharmaceutical preparations • Alabama
THIS INDENTURE OF LEASE (hereinafter referred to as the “Lease”), made and entered into this 1st day of June, 2006, is by and between THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA, a body corporate for its division the University of Alabama at Birmingham (hereinafter referred to as “LANDLORD” ) and DURECT CORPORATION (hereafter referred to as “TENANT”).
DURECT CORPORATION 4,444,444 Shares SUBSCRIPTION AGREEMENTSubscription Agreement • September 11th, 2009 • Durect Corp • Pharmaceutical preparations • New York
Each undersigned entity (each an “Investor” and collectively the “Investors”) hereby confirms and agrees with you as follows:
INDENTURE By and between DURECT CORPORATION and The Bank of New York, as Trustee Dated as of June 18, 2003Indenture • August 8th, 2003 • Durect Corp • Pharmaceutical preparations • New York
INDENTURE dated as of June 18, 2003 between DURECT Corporation, a Delaware corporation (hereinafter called the “Company”), having its principal office at 10240 Bubb Road, Cupertino, California 95014 and The Bank of New York, a New York banking corporation, as trustee hereunder (hereinafter called the “Trustee”).
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • March 14th, 2003 • Durect Corp • Pharmaceutical preparations • California
